<p id="thickbox_headline">The Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru, has signed a Letter of Intent (LoI) with Beyond Next Ventures (BNV), Japan, which is dedicated to incubation investment in tech startups.</p>.<p>The broad aim of this collaboration is to encourage and promote the best deep science innovations in life sciences and biotechnology. With the LoI, the two organisations intend to create C-CAMP – BNV Innovation Hub (CBIH), which will largely focus on facilitating Japanese investment of up to five million dollars in Indian startups working on technologies in life sciences and biotech.</p>.<p>The hub will support startups in both India and Japan, through exchange of human resources, technologies and other facilitation programmes to connect skilled talent, entrepreneurs and stakeholders.</p>.<p>Dr Taslimarif Saiyed, CEO and Director, C-CAMP, said that investment by the Japanese venture capital firm would help nurture more startups which are working on high-risk, high-return innovations in the sector.</p>.<p>“This will be a fantastic start to build Indo-Japanese collaborations for high-end innovations,” he said.</p>.<p>Tsuyoshi Ito, CEO, BNV, said the firm plans to make full-fledged venture investments in life sciences in India, which will contribute to industrial and economic development.</p>
<p id="thickbox_headline">The Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru, has signed a Letter of Intent (LoI) with Beyond Next Ventures (BNV), Japan, which is dedicated to incubation investment in tech startups.</p>.<p>The broad aim of this collaboration is to encourage and promote the best deep science innovations in life sciences and biotechnology. With the LoI, the two organisations intend to create C-CAMP – BNV Innovation Hub (CBIH), which will largely focus on facilitating Japanese investment of up to five million dollars in Indian startups working on technologies in life sciences and biotech.</p>.<p>The hub will support startups in both India and Japan, through exchange of human resources, technologies and other facilitation programmes to connect skilled talent, entrepreneurs and stakeholders.</p>.<p>Dr Taslimarif Saiyed, CEO and Director, C-CAMP, said that investment by the Japanese venture capital firm would help nurture more startups which are working on high-risk, high-return innovations in the sector.</p>.<p>“This will be a fantastic start to build Indo-Japanese collaborations for high-end innovations,” he said.</p>.<p>Tsuyoshi Ito, CEO, BNV, said the firm plans to make full-fledged venture investments in life sciences in India, which will contribute to industrial and economic development.</p>